Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Forte Biosciences, Inc. | 2,873,450 | reported | 14 Apr 2020 | tx 2+139,450 |
| Benitec Biopharma Inc. | 1,000,000 | reported | 09 Dec 2021 | tx 6+331,877 |
| IGC Pharma, Inc. | 772,196 | reported | 20 May 2009 | tx 15+1,316,054−3,497,627 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Apr 2021 | PURCHASE | Benitec Biopharma Inc. | 100,000 | 5.45 USD | first after silence |
| 29 Apr 2021 | PURCHASE | Benitec Biopharma Inc. | 22,877 | 5.49 USD | |
| 09 Dec 2021 | PURCHASE | Benitec Biopharma Inc. | 10,553 | 3.04 USD | |
| 03 May 2021 | PURCHASE | Benitec Biopharma Inc. | 40,500 | 4.25 USD | |
| 29 Nov 2021 | PURCHASE | Benitec Biopharma Inc. | 37,947 | 3.18 USD | |
| 30 Apr 2021 | PURCHASE | Benitec Biopharma Inc. | 120,000 | 4.18 USD | |
| 14 Apr 2020 | PURCHASE | Forte Biosciences, Inc. | 74,301 | 1.19 USD | |
| 02 Mar 2020 | PURCHASE | Forte Biosciences, Inc. | 65,149 | 1.35 USD | first after silence |
| 09 Jan 2009 | CONVERSION | IGC Pharma, Inc. | 70,833 | — | |
| 09 Jan 2009 | CONVERSION | IGC Pharma, Inc. | 80,401 | — | |
| 09 Jan 2009 | CONVERSION | IGC Pharma, Inc. | 964,812 | — | deriv |
| 09 Jan 2009 | CONVERSION | IGC Pharma, Inc. | 849,996 | — | deriv |
| 20 May 2009 | SALE | IGC Pharma, Inc. | 423,986 | 0.97 USD | |
| 19 May 2009 | SALE | IGC Pharma, Inc. | 178,424 | 1.15 USD | |
| 19 May 2009 | SALE | IGC Pharma, Inc. | 10,000 | 1.25 USD | |
| 18 May 2009 | SALE | IGC Pharma, Inc. | 80,401 | 1.01 USD | |
| 18 May 2009 | SALE | IGC Pharma, Inc. | 197,601 | 1.01 USD | |
| 19 May 2009 | SALE | IGC Pharma, Inc. | 646,599 | 1.27 USD | |
| 18 May 2009 | SALE | IGC Pharma, Inc. | 8 | 0.11 USD | deriv |
| 30 Sept 2008 | PURCHASE | IGC Pharma, Inc. | 200,000 | — | |
| 07 Mar 2008 | SALE | IGC Pharma, Inc. | 145,500 | 4.05 USD | |
| 10 Mar 2008 | SALE | IGC Pharma, Inc. | 300 | 4.14 USD | |
| 07 Mar 2008 | PURCHASE | IGC Pharma, Inc. | 964,820 | 0.37 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 28 Apr 2021.